Paris Court of Appeal - SAS SANTEN v/ INPI

Second medical indication and SPC - Referral to the CJEU - Gérard Dossmann, French IP and European patent attorney comments the decision of the Paris Court of Appeal of 9 october 2018 referring questions to the CJEU for a preliminary ruling on the interpretation of Article 3d) of Regulation (EC) No 469/2009 in the light of the NEURIM judgment (CJEU C-130/11).

Background The subject of the SANTEN’s patent: The use of a submicron oil-in-water ophthalmic emulsion comprising an immunosuppressive agent selected from the group (...)

Grand Chamber of the CJEU - TEVA and others v/ GILEAD SCIENCES INC.

Gérard Dossmann, French and European Patent Attorney comments the judgment of 25 July 2018 of the Grand Chamber of the COURT OF JUSTICE OF THE EUROPEAN UNION (CJEU). The Chamber rules on the interpretation of article 3a) of Regulation (EC) No. 469/2009 applying a two stages criterion.

Background: The company GILEAD markets under the name TRUVADA®, an antiretroviral drug indicated for the treatment of HIV patients. This medicine contains two active (...)

EUIPO – Opposition Division - Gap Inc. c/ STMicroelectronics International N.V.

STMicroelectronics International N.V. was represented by Caroline Casalonga, Attorney- and Philippine Charles, Legal Counsel.


  • - Failure to use GAP’s marks for electronic components;
  • - No similarity between electronic components and mobile applications for online sales
"MIND THE GAP" In a decision rendered on 31 May 2018, the EUIPO’s Opposition Division rejected the opposition filed against the EU trade mark application gapDRIVE No. (...)